Product Details

Alfuzosin

Alfuzosin Hydrochloride
10 mg
Prolonged-Release Tablet


DIN/PIN/NPN

02447576

Manufacturer

Sivem Pharmaceuticals ULC

Formulary Listing Date

2020-06-30  

Unit Price

0.2601

Amount MOH Pays

0.2601

Coverage Status

Limited Use Product Chronic-Use Medication

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

G04CA01

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02245565 Xatral 1.0900 0.2601
02304678 Sandoz Alfuzosin 0.2601 0.2601
02443201 Auro-Alfuzosin 0.2601 0.2601
02315866 Apo-Alfuzosin 0.2601 0.2601
02447576 Alfuzosin 0.2601 0.2601
02519844 Alfuzosin 0.2601 0.2601
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
351 Indefinite

For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g., doxazosin, terazosin, tamsulosin) have been ineffective

352 Indefinite

For the management of benign prostatic hyperplasia where other formulary alpha blockers (e.g., doxazosin, terazosin, tamsulosin) have produced intolerable side effects.

 

EAP Criteria

NO

Product Monograph

View Monograph